Bioanalytical assay development and validation for the pharmacokinetic study of gmc1, a novel fkbp52 co-chaperone inhibitor for castration resistant prostate cancer
- Publication date
- 1 November 2020
- Publisher
- Digital Scholarship @ Texas Southern University